Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Drug Developer NuPathe Prices Downsized IPO

By Pharmaceutical Processing | August 6, 2010

NEW YORK (AP) — Drug developer NuPathe Inc. priced shares of a scaled-back initial public offering, raising $50 million, the company said Friday.

NuPathe, based in Conshohocken, Pa., priced 5 million shares for $10 apiece. It downsized its IPO plans Thursday, cutting the expected range for shares from $14 to $16 each to just $10.

Net proceeds from the IPO were $43.2 million after expenses, NuPathe said. It will use the money mainly to fund the path of its migraine treatment candidate, Zelrix, through the Food and Drug Administration’s regulatory process and sell it in the U.S. if approved.

The company, which currently generates no revenue, expects to ask for FDA approval of Zelrix during the fourth quarter and said it expects to start selling Zelrix in the U.S. in the first half of 2012.

It also has a potential Parkinson’s disease and a potential schizophrenia treatment in the laboratory stages of development.

Shares of NuPathe are expected to trade Friday under the “PATH” symbol on the Nasdaq Global Market.

 

Related Articles Read More >

This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
PHARMAP 2025: Pharma leaders converge in Berlin for fifth anniversary summit
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE